Moleculin Biotech, Inc. (MBRX) DCF Valuation

Moleculin Biotech, Inc. (MBRX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Moleculin Biotech, Inc. (MBRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Moleculin Biotech, Inc. (MBRX) DCF Calculator! Analyze authentic Moleculin financials, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Moleculin Biotech, Inc. (MBRX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -13.2 -19.5 -22.8 -30.5 -29.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 .3 .3 .2 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -13.4 -19.8 -23.1 -30.7 -29.6 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 10.7 15.2 70.9 43.1 23.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .1
Account Receivables, % 100 100 100 100 100
Inventories 2.2 1.9 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.2 1.1 1.4 2.1 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.4 .0 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -13.2 -17.1 -12.9 -29.0 -29.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -13.1 -17.9 -10.5 -28.1 -29.3 -2.4 .0 .0 .0 .0
WACC, % 11.9 11.82 11.61 11.87 11.91 11.82 11.82 11.82 11.82 11.82
PV UFCF
SUM PV UFCF -2.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -23
Equity Value 21
Diluted Shares Outstanding, MM 2
Equity Value Per Share 10.54

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real MBRX financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Moleculin Biotech’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life MBRX Financials: Pre-filled historical and projected data for Moleculin Biotech, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Moleculin's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Moleculin's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Get the comprehensive Excel file featuring Moleculin Biotech, Inc. (MBRX) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare results.
  • Make Decisions: Leverage the valuation insights to inform your investment approach.

Why Choose This Calculator for Moleculin Biotech, Inc. (MBRX)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your analytical needs.
  • Real-Time Valuation: Observe immediate updates to Moleculin's valuation with input changes.
  • Preloaded Data: Comes equipped with Moleculin's latest financial information for swift evaluations.
  • Endorsed by Experts: Preferred by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Moleculin Biotech, Inc. (MBRX) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Moleculin Biotech, Inc. (MBRX).
  • Consultants: Deliver professional valuation insights for Moleculin Biotech, Inc. (MBRX) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Moleculin Biotech, Inc. (MBRX) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Moleculin Biotech, Inc. (MBRX).

What the Template Contains

  • Historical Data: Includes Moleculin Biotech, Inc.'s (MBRX) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Moleculin Biotech, Inc.'s (MBRX) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Moleculin Biotech, Inc.'s (MBRX) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.